Arkolith/Insider Trading/OCEL/Form 4

Skycrest Holdings, LLC

10% OwnerOrganicell Regenerative Medicine, Inc. (OCEL) · full profile →Form 4 · filed Jun 28, 2023
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2023Buy(P)800K$0.01$8K50.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-23-004454) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML